iCAD
iCAD provides AI-powered breast and colon health solutions for early cancer detection and risk assessment.
About iCAD
iCAD delivers AI-driven clinical solutions focused on breast and colon health, designed to support radiologists in early cancer detection and risk assessment. Its technology integrates with existing medical imaging workflows, leveraging artificial intelligence to analyze mammograms and other scans for subtle signs of disease. The platform emphasizes density assessment and risk evaluation, aiming to improve diagnostic accuracy and patient outcomes without replacing clinical expertise.
By applying deep learning algorithms to medical imaging, iCAD helps identify potential abnormalities that might be missed during traditional review. The tools are intended to enhance efficiency in high-volume screening environments while maintaining high sensitivity for cancer detection. As a healthcare technology provider, iCAD prioritizes seamless integration with picture archiving and communication systems (PACS) and other radiology platforms, offering scalable solutions for hospitals and imaging centers focused on breast and colorectal cancer screening programs.